This graph shows the number of people having initiated treatment for pre-exposure prophylaxis against the human immunodeficiency viruses (HIV) on a regional scale in France. Between January 2016 and June 2019, more than nine thousand people had started such a treatment in the Paris region of Île-de-France.
Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 2nd semester of 2019, by region
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
ANSM. (November 1, 2019). Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 2nd semester of 2019, by region [Graph]. In Statista. Retrieved September 28, 2020, from https://www.statista.com/statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. "Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 2nd semester of 2019, by region." Chart. November 1, 2019. Statista. Accessed September 28, 2020. https://www.statista.com/statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. (2019). Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 2nd semester of 2019, by region. Statista. Statista Inc.. Accessed: September 28, 2020. https://www.statista.com/statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM. "Number of People Having Started Treatment with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between The 1st Semester of 2016 and The 2nd Semester of 2019, by Region." Statista, Statista Inc., 1 Nov 2019, https://www.statista.com/statistics/1116558/hiv-aids-prep-initiations-france-region/
ANSM, Number of people having started treatment with Truvada® or generic for pre-exposure prophilaxis (PrEP) between the 1st semester of 2016 and the 2nd semester of 2019, by region Statista, https://www.statista.com/statistics/1116558/hiv-aids-prep-initiations-france-region/ (last visited September 28, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
